PIP/PIPW-B
SURVEYS 2014
AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
Performance Improvement
Program in Surgical Pathology
PARTICIPANT SUMMARY
This document is available on e-LAB Solutions™.
© 2014 College of American Pathologists. The College does not permit reproduction of any substantial
portion of the material in this Report without its written authorization. The College hereby authorizes
participants in the program to use the material in this Report solely for educational purposes within their
own institutions. The College prohibits use of the material in the Report — and any unauthorized use of the
College’s name or logo — in connection with promotional efforts by marketers of laboratory equipment,
reagents, materials, or services. Data from this program do not necessarily indicate the superiority or
inferiority of instruments, reagents, or other materials used by participating laboratories. Use of these data to
suggest such superiority or inferiority may be deceptive and misleading. The College will take all steps open
to it under the law to prevent unauthorized reproduction of substantial portions of the material in this
Report, deceptive use of any such material, and any unauthorized use of the College’s name or logo in
connection with promotional efforts by marketers of laboratory equipment, reagents, materials, or services.
2014 PIP/PIPW-B
PARTICIPANT SUMMARY
Program Update
This report summarizes the diagnostic responses for set B of the 2014 Performance
Improvement Program in Surgical Pathology (PIP & PIPW).
A tabulation of the responses to the supplementary questions is not included since these
are intended for educational purposes only.
SURGICAL PATHOLOGY COMMITTEE
Philip A. Branton, MD FCAP, Chair
Rochelle A. Simon, MD FCAP, Vice Chair
Aleodor Alexandru Andea, MBA, MD FCAP
Aaron Auerbach, MD FCAP
Brad B. Bryan, MD FCAP
Simion Ion Chiosea, MD FCAP
William V. Chopp, MD FCAP
Amy M. Coffey, MD-J
Byron E. Crawford, MD FCAP
H. Parry Dilworth, MD FCAP
Julie C. Fanburg-Smith, MD FCAP
Alyssa M. Krasinskas, MD FCAP
Tamera J. Lillemoe, MD FCAP
Daniel J. Luthringer, MD FCAP
Marisa Rose Nucci, MD FCAP
Nilsa C. Ramirez, MD FCAP
Kirtee Raparia, MD FCAP
Vijaya B. Reddy MD, MBA FCAP
Thomas S. Winokur, MD FCAP
Diagnosis
(2858) Hepatic epithelioid hemangioendothelioma
Case # 2014-11
Code
2056
1008
1872
2858
2859
1730
Diagnosis
Angiosarcoma
Cholangiocarcinoma
Cirrhosis
Hepatic epithelioid
hemangioendothelioma
Metastatic signet ring cell carcinoma
Sclerosed hemangioma
PIP Participants
No.
%
PIPW Participants
No.
%
131
70
19
5699
2.2
1.2
0.3
95.6
4
6
3.6
5.5
4
91
3.6
82.7
10
28
0.2
0.5
1
4
1.0
3.6
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2559
1405
1434
147
10
46.0
25.3
25.8
2.7
0.2
Diagnosis
(2702) Familial adenomatous polyposis
Case # 2014-12
Code
Diagnosis
2702
2860
2703
2861
Familial adenomatous polyposis
Juvenile polyposis syndrome
Lynch syndrome
MUTYH-associated polyposis
2862
Sporadic adenomas
PIP Participants
No.
%
PIPW Participants
No.
%
5918
31
11
-
99.3
0.5
0.2
-
104
2
1
1
96.3
1.9
0.9
0.9
-
-
0
0.0
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2382
1329
1538
247
17
43.2
24.1
27.9
4.5
0.3
Diagnosis
(2383) Seminoma
Case # 2014-13
Code
1994
2470
2383
2341
2271
2863
Diagnosis
Embryonal carcinoma
Malignant lymphoma
Seminoma
Sertoli cell tumor
Spermatocytic seminoma
Yolk sac tumor, solid pattern
PIP Participants
No.
%
15
6
5900
11
22
4
0.3
0.1
99.0
0.2
0.3
0.1
PIPW Participants
No.
%
0
1
96
0
7
0
0.0
1.0
92.3
0.0
6.7
0.0
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2484
1370
1510
164
20
44.7
24.7
27.2
3.0
0.4
Diagnosis
(1486) Cellular schwannoma
Case # 2014-14
Code
1486
2864
2159
2359
1647
2865
1584
2068
Diagnosis
Cellular schwannoma
Classic schwannoma
Malignant peripheral nerve sheath tumor
Neurofibroma
Sarcomatoid carcinoma
Solitary fibrous tumor, malignant
Spindle cell melanoma
Synovial sarcoma
PIP Participants
No.
%
5503
325
27
12
2
65
0
19
92.4
5.4
0.5
0.2
0.1
1.1
0.0
0.3
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2485
1422
1477
121
14
45.0
25.8
26.7
2.2
0.3
PIPW Participants
No.
%
52
27
1
6
0
17
0
0
50.5
26.2
1.0
5.8
0.0
16.5
0.0
0.0
Diagnosis
(2070) Endometrioid carcinoma
Case # 2014-15
Code
Diagnosis
2216
Clear cell carcinoma
2070
2866
Endometrioid carcinoma
Mucinous carcinoma/serous carcinoma
PIP Participants
No.
%
86
5858
11
1.4
98.4
0.2
PIPW Participants
No.
%
0
0.0
99
2
98.0
2.0
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2428
1364
1505
207
24
44.0
24.7
27.2
3.7
0.4
Diagnosis
(1698) Aggressive angiomyxoma
Case # 2014-16
Code
1698
1906
1752
1372
2867
1509
Diagnosis
Aggressive angiomyxoma
Angiomyofibroblastoma
Cellular angiofibroma
Fibroepithelial stromal polyp
Massive vulval edema
Superficial angiomyxoma
PIP Participants
No.
%
5829
36
12
7
14
55
98.0
0.6
0.2
0.1
0.2
0.9
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2402
1395
1494
169
27
43.8
25.4
27.2
3.1
0.5
PIPW Participants
No.
%
87
2
1
1
1
7
87.9
2.0
1.0
1.0
1.0
7.1
Diagnosis
(2060) Littoral cell angioma
Case # 2014-17
Code
1630
2060
2868
2869
1546
2870
Diagnosis
Hairy cell leukemia
Littoral cell angioma
Sclerosing angiomatoid nodular
transformation
Splenic angiosarcoma
Splenic hemangioma
Splenic lymphangioma
PIP Participants
No.
%
PIPW Participants
No.
%
12
5685
55
0.2
95.6
0.9
2
68
11
2.1
70.8
11.5
8
171
18
0.1
2.9
0.3
2
12
1
2.1
12.5
1.0
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2320
1434
1542
174
21
42.2
26.1
28.1
3.2
0.4
Diagnosis
(1990) Splenic marginal zone lymphoma
Code
Case # 2014-18
2643
1800
1630
2408
2334
1990
2871
Diagnosis
Chronic lymphocytic leukemia/small
lymphocytic lymphoma
Follicular lymphoma
Hairy cell leukemia
Hepatosplenic T-cell lymphoma
Mantle cell lymphoma
Splenic marginal zone lymphoma
T-cell large granular lymphocytic leukemia
PIP Participants
No.
%
26
0.4
5
5.3
17
110
8
82
5700
3
0.3
1.9
0.1
1.4
95.8
0.1
1
19
1
6
63
0
1.0
20.0
1.0
6.3
66.4
0.0
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIPW Participants
No.
%
PIP Participants
No.
%
2391
1452
1490
123
9
43.6
26.6
27.3
2.3
0.2
Diagnosis
(2216) Clear cell carcinoma
Case # 2014-19
Code
2216
2461
2462
2465
2377
2467
Diagnosis
Clear cell carcinoma
Dysgerminoma
Krukenberg tumor
Metastatic renal cell carcinoma
Serous borderline tumor
Yolk sac tumor
PIP Participants
No.
%
PIPW Participants
No.
%
5736
8
96.4
0.1
74
1
78.0
1.0
4
7
178
17
0.1
0.1
3.0
0.3
2
1
17
0
2.0
1.0
18.0
0.0
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2401
1389
1522
170
19
43.5
25.3
27.7
3.1
0.4
Diagnosis
(2873) Nephroblastoma (Wilms tumor)
Case # 2014-20
Code
2743
2872
1666
2873
2320
1317
Diagnosis
Clear cell sarcoma
Lymphoma/leukemia
Metanephric adenoma
Nephroblastoma (Wilms tumor)
Primitive neuroectodermal tumor
Rhabdoid tumor
PIP Participants
No.
%
12
1
9
5831
81
6
0.2
0.1
0.2
98.0
1.4
0.1
Technical Quality of Slide
Rating
001
002
003
004
005
Glass Slide Evaluation
Excellent
Satisfactory
Unsatisfactory
PIP Participants
No.
%
2697
1263
1385
115
15
49.2
23.1
25.3
2.1
0.3
PIPW Participants
No.
%
4
0
1
70
15
3
4.3
0.0
1.1
75.3
16.1
3.2